Filing Details

Accession Number:
0001209191-21-034685
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-20 20:16:34
Reporting Period:
2021-05-18
Accepted Time:
2021-05-20 20:16:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651944 Dermtech Inc. DMTK Services-Medical Laboratories (8071) 842870849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1787129 Enrico Picozza C/O Dermtech, Inc.
11099 N. Torrey Pines Rd. Suite 100
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-18 19,826 $37.38 786,036 No 4 S Indirect By HLM Venture Partners IV, L.P.
Common Stock Disposition 2021-05-18 1,300 $38.05 784,736 No 4 S Indirect By HLM Venture Partners IV, L.P.
Common Stock Disposition 2021-05-19 111,168 $35.55 673,568 No 4 S Indirect By HLM Venture Partners IV, L.P.
Common Stock Disposition 2021-05-19 28,849 $36.10 644,719 No 4 S Indirect By HLM Venture Partners IV, L.P.
Common Stock Disposition 2021-05-20 34,202 $36.00 610,517 No 4 S Indirect By HLM Venture Partners IV, L.P.
Common Stock Disposition 2021-05-20 45,498 $37.04 565,019 No 4 S Indirect By HLM Venture Partners IV, L.P.
Common Stock Disposition 2021-05-20 15,019 $37.46 550,000 No 4 S Indirect By HLM Venture Partners IV, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By HLM Venture Partners IV, L.P.
No 4 S Indirect By HLM Venture Partners IV, L.P.
No 4 S Indirect By HLM Venture Partners IV, L.P.
No 4 S Indirect By HLM Venture Partners IV, L.P.
No 4 S Indirect By HLM Venture Partners IV, L.P.
No 4 S Indirect By HLM Venture Partners IV, L.P.
No 4 S Indirect By HLM Venture Partners IV, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,000 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $37.00 to $37.98, inclusive. The reported price reflects the weighted-average sale price.
  2. The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  3. This transaction was executed in multiple trades at prices ranging from $38.01 to $38.13, inclusive. The reported price reflects the weighted-average sale price.
  4. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.99, inclusive. The reported price reflects the weighted-average sale price.
  5. This transaction was executed in multiple trades at prices ranging from $36.00 to $36.36, inclusive. The reported price reflects the weighted-average sale price.
  6. This transaction was executed in multiple trades at prices ranging from $35.29 to $36.28, inclusive. The reported price reflects the weighted-average sale price.
  7. This transaction was executed in multiple trades at prices ranging from $36.29 to $37.28, inclusive. The reported price reflects the weighted-average sale price.
  8. This transaction was executed in multiple trades at prices ranging from $37.30 to $37.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) through (8) of this Form 4.